BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harpaz N, Ward SC, Mescoli C, Itzkowitz SH, Polydorides AD. Precancerous lesions in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2013;27:257-267. [PMID: 23809244 DOI: 10.1016/j.bpg.2013.03.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Koehler BC, Jäger D, Schulze-Bergkamen H. Targeting cell death signaling in colorectal cancer: Current strategies and future perspectives. World J Gastroenterol 2014; 20(8): 1923-1934 [PMID: 24587670 DOI: 10.3748/wjg.v20.i8.1923] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
2 Saraggi D, Fassan M, Mescoli C, Scarpa M, Valeri N, Michielan A, D’incá R, Rugge M. The molecular landscape of colitis-associated carcinogenesis. Digestive and Liver Disease 2017;49:326-30. [DOI: 10.1016/j.dld.2016.12.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
3 Kamarádová K, Vošmiková H, Rozkošová K, Ryška A, Tachecí I, Laco J. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience. Pathol Res Pract 2019;215:730-7. [PMID: 30679085 DOI: 10.1016/j.prp.2019.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Schønfeldt Troelsen F, Sørensen HT, Pedersen L, Erichsen R. Risk of a post-colonoscopy colorectal cancer diagnosis in patients with inflammatory bowel disease: a population-based cohort study. Endoscopy 2021;53:1023-33. [DOI: 10.1055/a-1322-6574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
6 Cao L. Assessment of thyroid cancer risk in more than 334,000 patients with inflammatory bowel disease: a case-control study and a meta-analysis. World J Surg Oncol 2018;16:182. [PMID: 30200972 DOI: 10.1186/s12957-018-1485-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lu MJ, Qiu XY, Mao XQ, Li XT, Zhang HJ. Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2018;47:318-31. [DOI: 10.1111/apt.14436] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
8 Gui X, Köbel M, Ferraz JGP, Iacucci M, Ghosh S, Demetrick DJ. Newly recognized non-adenomatous lesions associated with enteric carcinomas in inflammatory bowel disease - Report of six rare and unique cases. Ann Diagn Pathol 2020;44:151455. [PMID: 31862522 DOI: 10.1016/j.anndiagpath.2019.151455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Villanacci V, Reggiani-Bonetti L, Caprioli F, Saragoni L, Salviato T, Mescoli C, Canavese G, Manenti S, Spada E, Baron L, Leoncini G, Cadei M, Battista S, Armuzzi A. Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC). Dig Liver Dis 2020;52:262-7. [PMID: 31884010 DOI: 10.1016/j.dld.2019.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Troelsen FS, Sørensen HT, Crockett SD, Pedersen L, Erichsen R. Characteristics and Survival of Patients With Inflammatory Bowel Disease and Postcolonoscopy Colorectal Cancers. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00577-2. [PMID: 34051380 DOI: 10.1016/j.cgh.2021.05.039] [Reference Citation Analysis]
11 Gui X, Köbel M, Ferraz JG, Iacucci M, Ghosh S, Liu S, Ou Y, Perizzolo M, Winkfein RJ, Rambau P, Demetrick DJ. Histological and molecular diversity and heterogeneity of precancerous lesions associated with inflammatory bowel diseases. J Clin Pathol 2020;73:391-402. [PMID: 31801800 DOI: 10.1136/jclinpath-2019-206247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kotsafti A, DʼIncà R, Scarpa M, Fassan M, Angriman I, Mescoli C, Bortoli N, Brun P, Bardini R, Rugge M, Savarino E, Zingone F, Castoro C, Castagliuolo I, Scarpa M. Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis. Clin Transl Gastroenterol 2019;10:e00061. [PMID: 31343468 DOI: 10.14309/ctg.0000000000000061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Qiu X, Ma J, Wang K, Zhang H. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Oncotarget. 2017;8:1031-1045. [PMID: 27906680 DOI: 10.18632/oncotarget.13715] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
14 Gamage SMK, Lee KTW, Dissabandara DLO, Lam AK, Gopalan V. Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression. Exp Mol Pathol 2021;120:104642. [PMID: 33905708 DOI: 10.1016/j.yexmp.2021.104642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Kamarádová K, Vošmiková H, Rozkošová K, Ryška A, Tachecí I, Laco J. Non-conventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease—results of molecular and immunohistochemical single institutional study. Virchows Arch 2020;476:231-41. [DOI: 10.1007/s00428-019-02627-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Principi M, Barone M, Pricci M, De Tullio N, Losurdo G, Ierardi E, Di Leo A. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol 2014; 20(33): 11496-11504 [PMID: 25206257 DOI: 10.3748/wjg.v20.i33.11496] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
17 Troelsen FS, Sørensen HT, Pedersen L, Erichsen R. Risk of a post-colonoscopy colorectal cancer in patients with type 2 diabetes: a Danish population-based cohort study. BMJ Open Gastroenterol 2021;8:e000786. [PMID: 34952850 DOI: 10.1136/bmjgast-2021-000786] [Reference Citation Analysis]
18 Wan D, Bruni SG, Dufton JA, O'brien P. Differential Diagnosis of Colonic Strictures: Pictorial Review with Illustrations from Computed Tomography Colonography. Can Assoc Radiol J 2015;66:259-71. [DOI: 10.1016/j.carj.2015.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Isidro RA, Cruz ML, Isidro AA, Baez A, Arroyo A, González-Marqués WA, González-Keelan C, Torres EA, Appleyard CB. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. World J Gastroenterol 2015; 21(6): 1749-1758 [PMID: 25684939 DOI: 10.3748/wjg.v21.i6.1749] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
20 Garziera M, Toffoli G. Inhibition of host immune response in colorectal cancer: Human leukocyte antigen-G and beyond. World J Gastroenterol 2014; 20(14): 3778-3794 [PMID: 24744572 DOI: 10.3748/wjg.v20.i14.3778] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
21 Mackiewicz T, Sowa A, Fichna J. Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends. Curr Drug Targets 2021;22:137-45. [PMID: 32077822 DOI: 10.2174/1389450121666200220123844] [Reference Citation Analysis]
22 Kasembeli MM, Bharadwaj U, Robinson P, Tweardy DJ. Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment. Int J Mol Sci 2018;19:E2299. [PMID: 30081609 DOI: 10.3390/ijms19082299] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
23 Fassan M, Baffa R, Kiss A. Advanced precancerous lesions within the GI tract: the molecular background. Best Pract Res Clin Gastroenterol. 2013;27:159-169. [PMID: 23809238 DOI: 10.1016/j.bpg.2013.03.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
24 Flores BM, O'Connor A, Moss AC. Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis. Gastrointest Endosc 2017; 86: 1006-1011. e8. [PMID: 28750838 DOI: 10.1016/j.gie.2017.07.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
25 Baker KT, Salk JJ, Brentnall TA, Risques RA. Precancer in ulcerative colitis: the role of the field effect and its clinical implications. Carcinogenesis 2018;39:11-20. [PMID: 29087436 DOI: 10.1093/carcin/bgx117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
26 Bennani A, Kharrasse G, Achraf M, Wafa K, Zahi I, Imane K, Mohamed B. Synchronous colonic adenoma and intestinal marginal zone B-cell lymphoma associated with Crohn's disease: a case report and literature review. BMC Cancer. 2019;19:966. [PMID: 31623635 DOI: 10.1186/s12885-019-6224-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Jeppsson S, Srinivasan S, Chandrasekharan B. Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferation. Am J Physiol Gastrointest Liver Physiol 2017;312:G103-11. [PMID: 27856419 DOI: 10.1152/ajpgi.00410.2015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
28 Ko HM, Harpaz N, Mcbride RB, Cui M, Ye F, Zhang D, Ullman TA, Polydorides AD. Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol 2015;28:1584-93. [DOI: 10.1038/modpathol.2015.111] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
29 Zhu Z, Mei Z, Guo Y, Wang G, Wu T, Cui X, Huang Z, Zhu Y, Wen D, Song J, He H, Xu W, Cui L, Liu C. Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis. J Crohns Colitis. 2018;12:546-558. [PMID: 29370346 DOI: 10.1093/ecco-jcc/jjy006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
30 Tranter-Entwistle I, Mullaney TG, Noah K, Pearson J, Falvey J, Gearry R, Eglinton T. Long-term incidence of dysplasia and colorectal cancer in an ulcerative colitis population-based cohort. ANZ J Surg 2020;90:821-5. [PMID: 31970885 DOI: 10.1111/ans.15686] [Reference Citation Analysis]